Incidental findings and the need for a revised informed consent process.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 23902536.
- Also identified by DOI 10.2214/AJR.13.11138.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The current clinical practice with regard to incidental findings (IFs) is suboptimal in the domains of informed consent and patient education. We argue that a more robust informed consent process is needed to enable patients to anticipate incidentalomas and to correctly perceive the associated risks. Given that IFs are very common in high-resolution imaging, patients should be provided information about the possibility of an IF as part of radiologic informed consent. The frequency of IFs, the very high rates of false-positives among incidentalomas, the very low rates of malignancies among incidentalomas, and the potential financial and emotional costs to both patients and the health care system of monitoring IFs necessitate a thorough informed consent process. Further, because radiologists are the most knowledgeable professionals regarding the nature of IFs, they should be the specialists who conduct the informed consent discussion with patients.
Medical subject headings
- Adrenal Gland Diseases
- Diagnostic Imaging
- Incidental Findings
- Informed Consent
- Tomography, X-Ray Computed